Study wrapper · #1134
Integrating GLP-1 Receptor Agonists Into Dermatology Practice: Safety and Monitoring Strategies.
Editor's note
Useful consolidation of the dermatologic side-effect picture for the GLP-1 class, written for practicing dermatologists but readable as a map of what to watch for. The headline items — alopecia, eruptions, facial volume loss — are drawn from associations of varying strength, and the authors are careful to label the rarer signals as emerging rather than established. A solid reference piece as this drug class moves further into cosmetic and skin-adjacent territory.
Plain-language abstract
A dermatology-focused review catalogs the skin and whole-body side effects being seen as GLP-1 drugs like semaglutide and retatrutide become widespread — from hair loss and rashes to the facial volume loss dubbed 'Ozempic face' — and outlines how clinicians should monitor for them.